Capio Biosciences Korea will expand to Gangwon Technopark

Capio Biosciences Korea is one of four companies selected to receive support from Hongcheon-gun to open a second office within the Hongcheon National Antibody Cluster within Gangwon Technopark. The local government will provide a half million dollars US over the next two years.